You are here


10 August 2022

With the new funds, Oper plans to boost its R&D investments, recruitment commitments and international growth.

8 August 2022

With another EUR 40.5 million raised, the biotech firm supports the next stage of its clinical development.

8 August 2022

Labcorp will be expanding its automated clinical trial kit production line in Mechelen to serve 70+ countries.

11 July 2022

The new spin-off of research center imec and university VUB, has completed a capital round of EUR 7 million.

5 July 2022

The new equipment mainly enables food firms to conduct tests with very small quantities of a basic substance.

5 July 2022

In the past five years, the number of additive manufacturing activities has no less than tripled at KU Leuven.

5 July 2022

Flanders’ companies, knowledge institutions and government spent 3.6% of the region’s GDP on R&D in 2020.

5 July 2022

The investment focuses on additional R&D capacity, smart factory expansion, new production technology, etc.

5 July 2022

By joining European cloud software leader Visma, Teamleader will be able to accelerate its growth ambitions.

30 June 2022

Flanders-based ADx Neurosciences, specializing in tailor-made antibodies and diagnostic methods, has been acquired by Japanese multinational Fujirebio.


More news about Flanders?

  • Regular updates
  • No spam

Interested in doing business in Flanders?

Let us help you!

  • We can introduce you to other companies, banks and regulators
  • We organize site visits to real estate locations
  • We assist with all legal aspects of setting up a business
  • We're an official government agency
  • Our services are completely free
  • We are a team of international experts

Receive our handbook to growing your business in Flanders

  • It's completely free.
  • Get an overview of all incentives relevant to your company.
  • Tax system explained in-depth.
  • Learn how to set up your business quickly.
  • Discover the benefits of Flanders (in addition to the chocolate).

In addition to the ebook, I agree to receive one or two follow-up emails

Subscribe to News